دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of Nebulized Magnesium vs Placebo Added to Albuterol on Hospitalization Among Children With Refractory Acute Asthma Treated in the Emergency Department
Suzanne Schuh, MD1,2; Judy Sweeney, RN, BScN1; Maggie Rumantir, MD1; Allan L. Coates, MDCM, BEng3; Andrew R. Willan, PhD4,5; Derek Stephens, MSc, BSc6; Eshetu G. Atenafu, MSc7; Yaron Finkelstein, MD2,8; Graham Thompson, MD9,10; Roger Zemek, MD11,12; Amy C. Plint, MD, MSc11,12; Jocelyn Gravel, MD, MSc13,14; Francine M. Ducharme, MD, MSc13,14; David W. Johnson, MD15,16; Karen Black, MD, MSc17; Sarah Curtis, MD18; Darcy Beer, MD19,20; Terry P. Klassen, MD, MSc21,22; Darcy Nicksy, BSc, PhM23; Stephen B. Freedman, MDCM, MSc24; for the Pediatric Emergency Research Canada (PERC) Network
doi : 10.1001/jama.2020.19839
JAMA. 2020;324(20):2038-2047
While intravenous magnesium decreases hospitalizations in refractory pediatric acute asthma, it is variably used because of invasiveness and safety concerns. The benefit of nebulized magnesium to prevent hospitalization is unknown.
Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy
Janice L. Atkins, PhD1; Luke C. Pilling, PhD1,2; Jane A. H. Masoli, MBChB1,3; Chia-Ling Kuo, PhD2; Jeremy D. Shearman, DPhil4; Paul C. Adams, MD5; David Melzer, MBBCh, PhD1,2
doi : 10.1001/jama.2020.21566
JAMA. 2020;324(20):2048-2057
Hereditary hemochromatosis is predominantly caused by the HFE p.C282Y homozygous pathogenic variant. Liver carcinoma and mortality risks are increased in individuals with clinically diagnosed hereditary hemochromatosis, but risks are unclear in mostly undiagnosed p.C282Y homozygotes identified in community genotyping.
Association of State Certificate of Need Regulation With Procedural Volume, Market Share, and Outcomes Among Medicare Beneficiaries
Tarik K. Yuce, MD, MS1; Jeanette W. Chung, PhD1; Cynthia Barnard, PhD, MBA2; Karl Y. Bilimoria, MD, MS1,2
doi : 10.1001/jama.2020.21115
JAMA. 2020;324(20):2058-2068
Certificate of need laws provide state-level regulation of health system expenditure. These laws are intended to limit spending and control hospital expansion in order to prevent excess capacity and improve quality of care. Several states have recently introduced legislation to modify or repeal these regulations, as encouraged by executive order 13813, issued in October 2017 by the Trump administration.
COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries
Alyssa Bilinski, MSc1; Ezekiel J. Emanuel, MD, PhD2
doi : 10.1001/jama.2020.20717
JAMA. 2020;324(20):2100-2102
Pediatric Magnet Ingestions After Federal Rule Changes, 2009-2019
Michael R. Flaherty, DO1; Terry Buchmiller, MD2; Mark Vangel, PhD3; Lois K. Lee, MD, MPH4
doi : 10.1001/jama.2020.19153
JAMA. 2020;324(20):2102-2104
Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors
US Preventive Services Task Force
doi : 10.1001/jama.2020.21749
JAMA. 2020;324(20):2069-2075
Cardiovascular disease (CVD) is a leading cause of death in the US. Known modifiable risk factors for CVD include smoking, overweight and obesity, diabetes, elevated blood pressure or hypertension, dyslipidemia, lack of physical activity, and unhealthy diet. Adults who adhere to national guidelines for a healthy diet and physical activity have lower cardiovascular morbidity and mortality than those who do not. All persons, regardless of their CVD risk status, benefit from healthy eating behaviors and appropriate physical activity.
Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors
Elizabeth A. O’Connor, PhD1; Corinne V. Evans, MPP1; Megan C. Rushkin, MPH1; Nadia Redmond, MSPH1; Jennifer S. Lin, MD, MCR1
doi : 10.1001/jama.2020.17108
JAMA. 2020;324(20):2076-2094
Cardiovascular disease is the leading cause of death in the US, and poor diet and lack of physical activity are major factors contributing to cardiovascular morbidity and mortality.
Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
Harald Schmidt, PhD1; Lawrence O. Gostin, JD2; Michelle A. Williams, ScD3
doi : 10.1001/jama.2020.20571
JAMA. 2020;324(20):2023-2024
Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation
Beth P. Bell, MD, MPH1; José R. Romero, MD2,3; Grace M. Lee, MD, MPH4
doi : 10.1001/jama.2020.20847
JAMA. 2020;324(20):2025-2026
Answering Key Questions About COVID-19 Vaccines
Jesse L. Goodman, MD, MPH1; John D. Grabenstein, RPh, PhD2; M. Miles Braun, MD, MPH3
doi : 10.1001/jama.2020.20590
JAMA. 2020;324(20):2027-2028
Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation
Kathryn A. Phillips, PhD1,2; Michael P. Douglas, MS1; Deborah A. Marshall, PhD3,4
doi : 10.1001/jama.2020.19933
JAMA. 2020;324(20):2029-2030
Reflections of a COVID-19 Long Hauler
Jeffrey N. Siegelman, MD1
doi : 10.1001/jama.2020.22130
JAMA. 2020;324(20):2031-2032
Revisiting States’ Experience With Certificate of Need
Vivian Ho, PhD1,2
doi : 10.1001/jama.2020.20831
JAMA. 2020;324(20):2033-2035
Comprehensive Cardiovascular Health Promotion for Successful Prevention of Cardiovascular Disease
Sadiya S. Khan, MD, MSc1,2; Philip Greenland, MD2,3
doi : 10.1001/jama.2020.18731
JAMA. 2020;324(20):2036-2037
Herd Immunity and Implications for SARS-CoV-2 Control
Saad B. Omer, MBBS, MPH, PhD1,2; Inci Yildirim, MD, PhD, MSc1,3; Howard P. Forman, MD, MBA4,5
doi : 10.1001/jama.2020.20892
JAMA. 2020;324(20):2095-2096
Headache, Confusion, and Somnolence in a 27-Year-Old Woman
Rahul Sastry, MD1; Krisztina Moldovan, MD1; Tianyi Niu, MD1
doi : 10.1001/jama.2020.10167
JAMA. 2020;324(20):2097-2098
First It Was Masks; Now Some Refuse Testing for SARS-CoV-2
Rita Rubin, MA
doi : 10.1001/jama.2020.22003
JAMA. 2020;324(20):2015-2016
New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years
Anita Slomski, MA
doi : 10.1001/jama.2020.21706
JAMA. 2020;324(20):2017-2018
Hand Hygiene Gaps Identified
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.22227
JAMA. 2020;324(20):2021
Active Surveillance Testing to Prevent Staph Spread in NICUs
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.21775
JAMA. 2020;324(20):2021
Cantharidin Drug-Device Clears Molluscum Contagiosum Lesions
Anita Slomski, MA
doi : 10.1001/jama.2020.21436
JAMA. 2020;324(20):2020
Long-term Mortality Outcomes in Early Breast Cancer Screening Trial
Anita Slomski, MA
doi : 10.1001/jama.2020.22569
JAMA. 2020;324(20):2020
Fecal Transplant for Clostridioides difficile Effective in Practice
Anita Slomski, MA
doi : 10.1001/jama.2020.22572
JAMA. 2020;324(20):2020
Opportunistic Atrial Fibrillation Screening Doesn’t Catch More Cases
Anita Slomski, MA
doi : 10.1001/jama.2020.22574
JAMA. 2020;324(20):2020
Antibiotics on Par With Surgery for Appendicitis
Anita Slomski, MA
doi : 10.1001/jama.2020.22576
JAMA. 2020;324(20):2020
Study Aims to Identify Drugs That Could Be Repurposed for COVID-19
Rita Rubin, MA
doi : 10.1001/jama.2020.21726
JAMA. 2020;324(20):2019
Importance of Patient Input in Designing CRISPR Trials
Rita Rubin, MA
doi : 10.1001/jama.2020.22597
JAMA. 2020;324(20):2019
Aid for American Indian, Alaska Native Individuals Who Want to Quit Smoking
Rita Rubin, MA
doi : 10.1001/jama.2020.22599
JAMA. 2020;324(20):2019
What Is Herd Immunity?
Angel N. Desai, MD, MPH1; Maimuna S. Majumder, PhD, MPH2
doi : 10.1001/jama.2020.20895
JAMA. 2020;324(20):2113
Counseling on Healthy Diet and Physical Activity to Prevent Cardiovascular Disease
Jill Jin, MD, MPH1
doi : 10.1001/jama.2020.22344
JAMA. 2020;324(20):2114
Maternal Docosahexaenoic Acid Supplementation and Bronchopulmonary Dysplasia in Infants
Chris H. P. van den Akker, MD, PhD1; Wes Onland, MD, PhD1; Anton H. van Kaam, MD, PhD1
doi : 10.1001/jama.2020.19404
JAMA. 2020;324(20):2104-2105
Maternal Docosahexaenoic Acid Supplementation and Bronchopulmonary Dysplasia in Infants—Reply
Isabelle Marc, MD, PhD1; Pierre Julien, PhD2; Pascal M. Lavoie, MD, PhD3
doi : 10.1001/jama.2020.19410
JAMA. 2020;324(20):2105
Cardiovascular Risk Assessment for Noncardiac Surgery
Christian Grasshoff, MD, PhD1; Harry Magunia, MD1
doi : 10.1001/jama.2020.19407
JAMA. 2020;324(20):2105-2106
Cardiovascular Risk Assessment for Noncardiac Surgery—Reply
Nathaniel R. Smilowitz, MD, MS1; Jeffrey S. Berger, MD, MS1
doi : 10.1001/jama.2020.19416
JAMA. 2020;324(20):2106-2107
